Recurrent Childhood Lymphoblastic Lymphoma

specific

The reemergence of lymphoblastic lymphoma in childhood after a period of remission.

Centers

Active Trials

—

Cancer Funding

Top Centers for Recurrent Childhood Lymphoblastic Lymphoma(50)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive	—	—	51.0
2	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive	—	—	51.0
3	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive	—	—	51.0
4	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive	—	—	51.0
5	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive	—	—	51.0
6	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive	—	—	51.0
7	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive	—	—	51.0
8	Duke Cancer InstituteDurham, NC NCI Comprehensive	—	—	51.0
9	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive	—	—	51.0
10	Winship Cancer InstituteAtlanta, GA NCI Comprehensive	—	—	51.0
11	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive	—	—	51.0
12	OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive	—	—	51.0
13	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive	—	—	51.0
14	Comprehensive Cancer Center St. Jude Children’s Research HospitalMemphis, TN NCI Comprehensive	—	—	51.0
15	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	—	51.0
16	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive	—	—	51.0
17	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive	—	—	51.0
18	UF Health Cancer InstituteGainesville, FL NCI Clinical	—	—	51.0
19	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive	—	—	51.0
20	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	—	51.0
21	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical	—	—	51.0
22	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive	—	—	51.0
23	Medical College of Wisconsin Cancer CenterMilwaukee, WI	—	—	51.0
24	Cedars-Sinai CancerLos Angeles, CA	—	—	51.0
25	Cleveland Clinic Cancer CenterCleveland, OH	—	—	51.0
26	Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive	—	—	51.0
27	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical	—	—	51.0
28	Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive	—	—	51.0
29	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive	—	—	51.0
30	University of Illinois Cancer CenterChicago, IL	—	—	51.0
31	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical	—	—	51.0
32	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive	—	—	51.0
33	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR	—	—	51.0
34	Boston University Cancer CenterBoston, MA	—	—	51.0
35	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive	—	—	51.0
36	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX	—	—	51.0
37	Cancer Center at IllinoisUrbana, IL	—	—	51.0
38	Stony Brook Cancer CenterStony Brook, NY	—	—	51.0
39	Penn State Cancer InstituteHershey, PA	—	—	51.0
40	University of Cincinnati Cancer CenterCincinnati, OH	—	—	51.0
41	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL	—	—	51.0
42	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ	—	—	51.0
43	The University of Vermont Cancer CenterBurlington, VT	—	—	51.0
44	University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR	—	—	51.0
45	Upstate Cancer CenterSyracuse, NY	—	—	51.0
46	Loma Linda University Cancer CenterLoma Linda, CA	—	—	51.0
47	BC CancerVancouver, BC	—	—	51.0
48	Tampa General Hospital Cancer InstituteTampa, FL	—	—	51.0
49	Princess Margaret Cancer CentreToronto, ON	—	—	51.0
50	Louisiana Cancer Research CenterNew Orleans, LA	—	—	51.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →